BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15260848)

  • 1. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
    Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH
    Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
    Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
    Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma.
    Albores-Saavedra J; Chablé-Montero F; González-Romo MA; Ramírez Jaramillo M; Henson DE
    Hum Pathol; 2012 Sep; 43(9):1506-13. PubMed ID: 22386521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
    Xiong L; Yang Z; Yang L; Liu J; Miao X
    J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W
    Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
    Awaya H; Takeshima Y; Yamasaki M; Inai K
    Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mucins and cytokeratins in primary carcinomas of the digestive system.
    Lee MJ; Lee HS; Kim WH; Choi Y; Yang M
    Mod Pathol; 2003 May; 16(5):403-10. PubMed ID: 12748245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
    Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
    Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell change in colonic tubular adenoma and corresponding colonic clear cell adenocarcinoma is associated with an altered mucin core protein profile.
    Shi C; Scudiere JR; Cornish TC; Lam-Himlin D; Park JY; Fox MR; Montgomery EA
    Am J Surg Pathol; 2010 Sep; 34(9):1344-50. PubMed ID: 20697252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
    Lau SK; Weiss LM; Chu PG
    Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.
    Giorgadze TA; Peterman H; Baloch ZW; Furth EE; Pasha T; Shiina N; Zhang PJ; Gupta PK
    Cancer; 2006 Jun; 108(3):186-97. PubMed ID: 16628655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucins as key molecules for the classification of intestinal metaplasia of the stomach.
    Silva E; Teixeira A; David L; Carneiro F; Reis CA; Sobrinho-Simões J; Serpa J; Veerman E; Bolscher J; Sobrinho-Simões M
    Virchows Arch; 2002 Mar; 440(3):311-7. PubMed ID: 11889603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer.
    Wakatsuki K; Yamada Y; Narikiyo M; Ueno M; Takayama T; Tamaki H; Miki K; Matsumoto S; Enomoto K; Yokotani T; Nakajima Y
    J Surg Oncol; 2008 Aug; 98(2):124-9. PubMed ID: 18521835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
    Gürbüz Y; Kahlke V; Klöppel G
    Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.